US-based precision medicine platform operator GNS Healthcare received $23m on Tuesday in a series D round led by Cigna Ventures, the corporate venturing arm of healthcare provider Cigna.
Echo Health Ventures, which was formed by hospital manager Cambia Health Solutions with health insurer Blue Cross Blue Shield of North Carolina’s Mosaic Health Solutions vehicle, also took part in the round.
Pharmaceutical firms Celgene and Amgen, through its corporate venture capital subsidiary Amgen Ventures, filled out the round together with Alexandria Venture Investments, the strategic investment unit of life science real estate trust Alexandria Real Estate Equities.
The institutional investors were joined by Gary Loveman, former division president of managed care provider Aetna and former chief executive of gaming hotel and casino operator Caesar’s Entertainment.
GNS has developed a machine learning-powered platform that helps biopharmaceutical companies and health systems leverage data to match therapeutics, procedures and care plans to individual patients.
GNS previously collected $6m from Amgen Ventures and Alexandria Real Estate Equities in 2017, adding to $4m in funding obtained from undisclosed investors in November 2016, six months after collecting an undisclosed sum from healthcare provider Horizon Healthcare Services.
Diversified conglomerate Mitsui, healthcare company Cambia Health Solutions, care provider Heritage Provider Network and Gi Global Health Fund backed a $10m series C round in 2015, investing alongside Alexandria Real Estate Equities and Celgene.
Heritage Provider Network, Mitsui and Cambia Health all participated in a $10m series B in 2014, with the latter initially participating in the company’s $5m series A round in 2012.